D. Medical Industries, Ltd.
http://dmedicalindustries.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From D. Medical Industries, Ltd.
C&D Investors, Analysts Not On Same Page
Share price’s recent ride doesn’t track with analysts’ regard for C&D’s results and outlook.
Church & Dwight Cuts ‘Power’ Brands To Seven While Reporting, Forecasting Bigger Results
Health, personal and household care product marketer says raising its annual guidance model from 3% organic growth to 4% driven by expectations for international sales growth, a return to volume-driven sales growth and outlook for Hero and TheraBreath brands.
US Q4 Consumer Health Earnings Preview: Supply Chain Disruption Returns, Opill Launch Waits
Attacks on shipping since November in the Red Sea lead shipping lines to re-route vessels south of Africa, spiking shipping costs. Perrigo began 2024 saying it expects sales of Opill oral contraceptive to start early in the first quarter, but now expects to start late in the quarter.
Volume Returns As Church & Dwight Sales Driver With Economic Headwinds Not Ready To Leave
Higher costs and interest rates due to inflation as well as higher credit card debt point toward consumers spending less in areas including health, personal and household care products. C&D is “well-positioned for this trade down” with 40% of its portfolio in value products, says CEO Matthew Farrell.
Company Information
- Industry
- Biotechnology
- Miscellaneous
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Infusion Therapy Equipment and Supplies
-
In Vitro Diagnostics
- Glucose Testing
- Other Names / Subsidiaries
-
- D-Medical
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice